🦊/Lists

Biotech Investors & VC Firms in United States

1265 firms in this list, with a median first check of $500K. 278 of them lead rounds. Generated from verified public data and updated continuously.

Mission Biocapital
San FranciscoPre-Seed–Series A$500K
21 people
Rho Ventures
New YorkPre-Seed–Late Stage$2M – $15M
10 people
Alpha Edison
Los AngelesSeed–Series A$1M – $10M
14 people
Compound
New YorkSeed–Series A$400K – $1.5M
13 people
Avoro Capital Advisors
New YorkSeed–Series A
22 people
M Ventures
Los AngelesSeed–Growth$10.8M
6 people
Odyssey Investment Partners
New YorkGrowth–Late Stage$100M – $300M
24 people
Agent Capital
WalthamPre-Seed–Late Stage
26 people
TMV
New YorkPre-Seed–Series A$1.5M
14 people
K2 HealthVentures
BostonSeries A–Late Stage$10M – $100M
27 people
GroveStreet
NewtonSeries A–Late Stage
41 people
iSelect Fund
St. LouisSeed–Late Stage$250K – $2M
10 people
Rising Tide
PacificaPre-Seed–Series B
19 people
Safar Partners
CambridgePre-Seed–Late Stage
17 people
Signal Peak Ventures
Salt Lake CityPre-Seed–Series B$250K – $5M
16 people
NaviMed Capital
RosslynGrowth$5M – $30M
30 people
Alliance of Angels
SeattlePre-Seed–Seed
29 people
JDRF T1D Fund
BostonSeed–Late Stage
30 people
NYU Innovation Venture Fund
New YorkPre-Seed–Series A$100K – $500K
33 people
South Park Commons
San FranciscoPre-Seed–Seed$1M – $10M
15 people
Prototype Capital
Los AngelesPre-Seed–Series A
38 people
SVG Ventures | THRIVE
Silicon ValleyPre-Seed–Series A$10K – $100K
30 people
Launch NY
BuffaloPre-Seed–Seed$200K – $1M
5 people
ACME Capital
San FranciscoPre-Seed–Growth
13 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.